Eriocalyxin B inhibits nuclear factor-kappaB activation by interfering with the binding of both p65 and p50 to the response element in a noncompetitive manner - Leung, C H; Grill, S P; Lam, W (Proc Am Assoc Cancer Res, 2006)
et al.